FDA Approves New Treatments for Colorectal Cancer, Leukemia, and Melanoma
During the early part of summer 2018, the U.S. Food and Drug Administration (FDA) has approved several new anticancer...
Tag: immunotherapy
During the early part of summer 2018, the U.S. Food and Drug Administration (FDA) has approved several new anticancer...
This week marks the fourth anniversary of Cancer Research Catalyst, the official blog of the American Association for Cancer...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which pembrolizumab...
A study presented at the AACR Annual Meeting 2018 discussed preliminary data on an off-the-shelf, T-cell receptor (TCR)-less, dual-targeted...
Early this week, the U.S. Food and Drug Administration (FDA) approved a combination immunotherapy regimen for treating certain patients...
An exciting area in drug development, immunotherapy is being increasingly utilized by patients with different cancer types. These treatments...
While Cancer Research Catalyst covers the spectrum of cancer research news, we weren’t surprised to discover that the hottest...
Much has been written, including on this blog, about the rapidly expanding use of immunotherapy to treat an increasing...
In recent years, the U.S. Food and Drug Administration has approved immune checkpoint inhibitors, a class of immunotherapy, to...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which immunotherapeutics...